Press Release : MerLion Pharmaceuticals Completes Growth Financing Round
05/18/2021 | 03:31am EDT
Send by mail :
Message :
Required fields - Proceeds will be used to facilitate MerLion`s production and market
launch of Xtoro(TM) Berlin, (18/05/2021) - MerLion Pharmaceuticals GmbH (MerLion), a
biopharmaceutical company focused on research and development of novel
antibiotics for the treatment of serious bacterial infections, today
announced the successful completion of a growth financing round raised
via a private placement to European strategic investors. The funds raised will primarily be used to finance the production and
market launch of MerLion s US FDA and Health Canada approved drug
Xtoro(TM) , an otic suspension containing finafloxacin for treatment of